Effects of a selective inhibitor of type A monoamine oxidase--Lilly 51641--on behavior, sleep and circadian rhythms in depressed and schizophrenic patients

Commun Psychopharmacol. 1978;2(6):513-23.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Behavior / drug effects*
  • Circadian Rhythm / drug effects*
  • Clinical Trials as Topic
  • Cyclopropanes / pharmacology
  • Cyclopropanes / therapeutic use*
  • Depression / drug therapy*
  • Depression / psychology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Monoamine Oxidase Inhibitors / pharmacology
  • Monoamine Oxidase Inhibitors / therapeutic use*
  • Phenyl Ethers / pharmacology
  • Phenyl Ethers / therapeutic use
  • Placebos
  • Psychiatric Status Rating Scales
  • Schizophrenia / drug therapy*
  • Schizophrenic Psychology
  • Sleep / drug effects*

Substances

  • Cyclopropanes
  • Monoamine Oxidase Inhibitors
  • Phenyl Ethers
  • Placebos